2012
DOI: 10.1007/s00414-012-0741-3
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing in mice

Abstract: Dynamic localization of CB2R and quantitative analysis of CB2R mRNA during skin wound healing in mice were performed. Co-localization of CB2R with F4/80 or α-SMA was detected by double-color immunofluorescence microscopy. A total of 110 male mice were divided into control, injury, and postmortem groups. Sixty-five mice were sacrificed, followed by sampling at 0.5 h-21 days post-injury. Five mice without incision were used as control. The other 40 mice that received incised wound were sacrificed at 5 days after… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
42
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 49 publications
(45 citation statements)
references
References 31 publications
3
42
0
Order By: Relevance
“…Taking into account our previous finding that expression of CB 2 receptor was up-regulated during skin wound healing in mice (Zheng et al, 2012), we presumed CB 2 receptor might regulate skin wound healing, and pharmacomodulation of its activity might be a novel perspective for wound therapy. In the present study, we verified this hypothesis using Gp1a (highly selective CB 2 receptor agonist) and AM630 (highly selective CB 2 receptor antagonist) in mice skin excisional wounds in vivo and HaCaT keratinocytes in vitro.…”
Section: Introductionmentioning
confidence: 99%
“…Taking into account our previous finding that expression of CB 2 receptor was up-regulated during skin wound healing in mice (Zheng et al, 2012), we presumed CB 2 receptor might regulate skin wound healing, and pharmacomodulation of its activity might be a novel perspective for wound therapy. In the present study, we verified this hypothesis using Gp1a (highly selective CB 2 receptor agonist) and AM630 (highly selective CB 2 receptor antagonist) in mice skin excisional wounds in vivo and HaCaT keratinocytes in vitro.…”
Section: Introductionmentioning
confidence: 99%
“…Endocannabinoids function by binding to cannabinoid receptors and lipid signaling molecules such as the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα) (Di Marzo et al, 2001; Dubrac et al, 2011; Kendall et al, 2013; O'Sullivan et al, 2010). Two major G protein-coupled endocannabinoid receptors have been identified in the skin, CB1 and CB2 (Galiegue et al, 1995; Kupczyk et al, 2009; Pertwee, 2014; Stander et al, 2005; Zheng et al, 2012). Whereas binding of AEA to CB1 is involved in controlling keratinocyte growth, differentiation and apoptosis (Maccarrone et al, 2003; Paradisi et al, 2008), endocannabinoid signaling through CB2 regulates genes mediating lipid biosynthesis, immune cell signaling, cell migration and inflammation (Dobrosi et al, 2008; Kishimoto et al, 2005; Oka et al, 2006; Zheng et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Two major G protein-coupled endocannabinoid receptors have been identified in the skin, CB1 and CB2 (Galiegue et al, 1995; Kupczyk et al, 2009; Pertwee, 2014; Stander et al, 2005; Zheng et al, 2012). Whereas binding of AEA to CB1 is involved in controlling keratinocyte growth, differentiation and apoptosis (Maccarrone et al, 2003; Paradisi et al, 2008), endocannabinoid signaling through CB2 regulates genes mediating lipid biosynthesis, immune cell signaling, cell migration and inflammation (Dobrosi et al, 2008; Kishimoto et al, 2005; Oka et al, 2006; Zheng et al, 2012). PPARα has also been identified in the skin, specifically in keratinocytes, sebaceous glands and T-cells, and it is thought to play a role in wound re-epithelialization, sebocyte differentiation, and the resolution of inflammation (Di-Poi et al, 2004; Dubrac et al, 2011; Michalik et al, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…Several studies showed that the level of argininosuccinate lyase mRNA is stable for 18 h postmortem, that of the sodium-coupled neutral amino acid transporter (SNAT2) mRNA is stable for 48 h postmortem, and those of microtubule-associated protein 1A/1B-light chain 3 (LC3)-II and sequestosome 1 (p62) protein are stable for 4 days postmortem [28,46,47]. In contrast, cannabinoid receptor type-2 mRNA was degraded significantly at 3 h postmortem, and matrix metalloproteinase-2 and the tissue inhibitors of metalloproteinase-2 mRNA were significantly degraded at 12 h postmortem [27,48]. The degradation of RNA and protein caused by postmortem effects -especially putrefaction, decomposition, and desiccation -is inevitable after death.…”
Section: Biomarkers Of Wound Agingmentioning
confidence: 84%
“…After wounding, however, the mRNA levels of cytokines and enzymes typically change sooner than the protein levels and the histomorphology [25][26][27][28]. Hence, assays based on mRNA are suitable for estimating the age of early-stage wounds.…”
Section: Molecular Biological Analysismentioning
confidence: 99%